Arjo AB (publ) (ARJOBS.XC)
- Previous Close
32.15 - Open
32.15 - Bid 41.80 x --
- Ask --
- Day's Range
32.15 - 32.15 - 52 Week Range
30.78 - 47.36 - Volume
3,627 - Avg. Volume
352 - Market Cap (intraday)
8.351B - Beta (5Y Monthly) 0.57
- PE Ratio (TTM)
19.02 - EPS (TTM)
1.69 - Earnings Date Jul 11, 2025
- Forward Dividend & Yield 0.95 (2.95%)
- Ex-Dividend Date Apr 30, 2025
- 1y Target Est
--
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia care, bariatric room solutions, prone positioning, early mobility, architects and planners, and rehabilitation services, as well as equipment repair and maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. Arjo AB (publ) was founded in 1957 and is headquartered in Malmö, Sweden.
www.arjo.com6,500
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: ARJOBS.XC
View MorePerformance Overview: ARJOBS.XC
Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ARJOBS.XC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ARJOBS.XC
View MoreValuation Measures
Market Cap
7.84B
Enterprise Value
8.43B
Trailing P/E
19.02
Forward P/E
15.38
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.77
Price/Book (mrq)
1.12
Enterprise Value/Revenue
0.74
Enterprise Value/EBITDA
4.23
Financial Highlights
Profitability and Income Statement
Profit Margin
4.01%
Return on Assets (ttm)
3.90%
Return on Equity (ttm)
5.74%
Revenue (ttm)
11.4B
Net Income Avi to Common (ttm)
457M
Diluted EPS (ttm)
1.69
Balance Sheet and Cash Flow
Total Cash (mrq)
609M
Total Debt/Equity (mrq)
67.01%
Levered Free Cash Flow (ttm)
683.5M